vs
Side-by-side financial comparison of BJs RESTAURANTS INC (BJRI) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
BJs RESTAURANTS INC is the larger business by last-quarter revenue ($355.4M vs $207.8M, roughly 1.7× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 3.6%, a 53.8% gap on every dollar of revenue.
BJ's Restaurants Inc. operates a chain of casual dining restaurants across the United States. Its menu features signature deep-dish pizzas, craft beers, handcrafted cocktails, and a wide range of American comfort food. The brand primarily serves family groups, friend gatherings, and casual diners seeking affordable, high-quality meals in a relaxed, welcoming in-store environment.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
BJRI vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $355.4M | $207.8M |
| Net Profit | $12.6M | $119.2M |
| Gross Margin | 74.5% | — |
| Operating Margin | 3.1% | 52.2% |
| Net Margin | 3.6% | 57.4% |
| Revenue YoY | 3.2% | — |
| Net Profit YoY | -24.2% | 330.1% |
| EPS (diluted) | $0.58 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $355.4M | — | ||
| Q3 25 | $365.6M | $207.8M | ||
| Q2 25 | $348.0M | — | ||
| Q4 24 | $325.7M | — | ||
| Q3 24 | $349.9M | $0 | ||
| Q2 24 | $337.3M | $0 | ||
| Q1 24 | — | $0 | ||
| Q3 22 | — | $29.7M |
| Q4 25 | $12.6M | — | ||
| Q3 25 | $22.2M | $119.2M | ||
| Q2 25 | $13.5M | — | ||
| Q4 24 | $-2.9M | — | ||
| Q3 24 | $17.2M | $-51.8M | ||
| Q2 24 | $7.7M | $-52.8M | ||
| Q1 24 | — | $-39.6M | ||
| Q3 22 | — | $1.6M |
| Q4 25 | 74.5% | — | ||
| Q3 25 | 75.2% | — | ||
| Q2 25 | 75.0% | — | ||
| Q4 24 | 73.4% | — | ||
| Q3 24 | 74.3% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | 3.1% | — | ||
| Q3 25 | 5.8% | 52.2% | ||
| Q2 25 | 4.3% | — | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 2.2% |
| Q4 25 | 3.6% | — | ||
| Q3 25 | 6.1% | 57.4% | ||
| Q2 25 | 3.9% | — | ||
| Q4 24 | -0.9% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 5.4% |
| Q4 25 | $0.58 | — | ||
| Q3 25 | $0.97 | $1.33 | ||
| Q2 25 | $0.58 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $0.72 | $-0.60 | ||
| Q2 24 | $0.32 | $-0.68 | ||
| Q1 24 | — | $-0.53 | ||
| Q3 22 | — | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.8M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $366.2M | $1.1B |
| Total Assets | $1.0B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.8M | — | ||
| Q3 25 | $26.0M | $786.9M | ||
| Q2 25 | $19.0M | — | ||
| Q4 24 | $18.4M | — | ||
| Q3 24 | $16.2M | $920.0M | ||
| Q2 24 | $18.8M | $701.7M | ||
| Q1 24 | — | $698.8M | ||
| Q3 22 | — | $386.2M |
| Q4 25 | — | — | ||
| Q3 25 | $60.5M | — | ||
| Q2 25 | $85.5M | — | ||
| Q4 24 | $66.5M | — | ||
| Q3 24 | $63.5M | — | ||
| Q2 24 | $58.0M | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | $366.2M | — | ||
| Q3 25 | $386.6M | $1.1B | ||
| Q2 25 | $371.5M | — | ||
| Q4 24 | $376.2M | — | ||
| Q3 24 | $386.5M | $1.2B | ||
| Q2 24 | $375.4M | $931.7M | ||
| Q1 24 | — | $935.3M | ||
| Q3 22 | — | $368.8M |
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $1.0B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | $1.2B | ||
| Q2 24 | $1.0B | $973.7M | ||
| Q1 24 | — | $961.5M | ||
| Q3 22 | — | $410.9M |
| Q4 25 | — | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.23× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $62.3M | $142.2M | ||
| Q2 25 | $4.6M | — | ||
| Q4 24 | $27.3M | — | ||
| Q3 24 | $20.2M | $-49.2M | ||
| Q2 24 | $22.3M | $-32.9M | ||
| Q1 24 | — | $-43.8M | ||
| Q3 22 | — | $-24.2M |
| Q4 25 | — | — | ||
| Q3 25 | $41.9M | $142.2M | ||
| Q2 25 | $-12.1M | — | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $735.0K | $-49.7M | ||
| Q2 24 | $448.0K | $-33.9M | ||
| Q1 24 | — | $-45.1M | ||
| Q3 22 | — | $-25.3M |
| Q4 25 | — | — | ||
| Q3 25 | 11.5% | 68.4% | ||
| Q2 25 | -3.5% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | -85.1% |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | 0.0% | ||
| Q2 25 | 4.8% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 6.5% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 3.7% |
| Q4 25 | — | — | ||
| Q3 25 | 2.80× | 1.19× | ||
| Q2 25 | 0.34× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | -14.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
